Skip to main content
. 2020 Feb 21;43(4):1187–1198. doi: 10.3892/or.2020.7511

Figure 4.

Figure 4.

Overall survival (OS) based on different Ki67 expression levels according to AJCC-8 stratification. (A) 5-year OS in stage I (Breslow=133.31, P<0.001). (B) 5-year OS in stage II (Breslow=148.02, P<0.001). (C) 5-year OS in stage III (Breslow=38.77, P<0.001). (D) 5-year OS in stage IV (Breslow=3.40, P=0.334). AJCC-8, American Joint Committee on Cancer 8 edition.